196 related articles for article (PubMed ID: 30561882)
41. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
Kang X; Wang Y; Chen Z; Wu Y; Chen H; Yang X; Yu C
Chem Commun (Camb); 2020 Sep; 56(76):11271-11274. PubMed ID: 32830841
[TBL] [Abstract][Full Text] [Related]
42. Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand.
Martín Santos C; Cabrera S; Ríos-Luci C; Padrón JM; López Solera I; Quiroga AG; Medrano MA; Navarro-Ranninger C; Alemán J
Dalton Trans; 2013 Oct; 42(37):13343-8. PubMed ID: 23945635
[TBL] [Abstract][Full Text] [Related]
43. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, characterization and cytotoxicity of dihalogeno-platinum(II) complexes with L-histidine ligand.
Ye QS; Xie MJ; Liu WP; Chen XZ; Yu Y; Chang QW; Hou SQ
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):424-7. PubMed ID: 19336943
[TBL] [Abstract][Full Text] [Related]
45. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
Zhou Z; Chen F; Xu G; Gou S
Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
[TBL] [Abstract][Full Text] [Related]
46. Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells.
Barbanente A; Nadar RA; Esposti LD; Palazzo B; Iafisco M; van den Beucken JJJP; Leeuwenburgh SCG; Margiotta N
J Mater Chem B; 2020 Apr; 8(14):2792-2804. PubMed ID: 32159578
[TBL] [Abstract][Full Text] [Related]
47. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
[TBL] [Abstract][Full Text] [Related]
48. Selective bio-labeling and induced apoptosis of hematopoietic cancer cells using dual-functional polyethylenimine-caged platinum nanoclusters.
Chen X; Zhou J; Yue X; Wang S; Yu B; Luo Y; Huang X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1465-1470. PubMed ID: 30029883
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.
Banerjee S; Kitchen JA; Bright SA; O'Brien JE; Williams DC; Kelly JM; Gunnlaugsson T
Chem Commun (Camb); 2013 Oct; 49(76):8522-4. PubMed ID: 23942760
[TBL] [Abstract][Full Text] [Related]
50. A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines.
Petruzzella E; Braude JP; Aldrich-Wright JR; Gandin V; Gibson D
Angew Chem Int Ed Engl; 2017 Sep; 56(38):11539-11544. PubMed ID: 28759160
[TBL] [Abstract][Full Text] [Related]
51. Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexes.
Miodragović ĐU; Quentzel JA; Kurutz JW; Stern CL; Ahn RW; Kandela I; Mazar A; O'Halloran TV
Angew Chem Int Ed Engl; 2013 Oct; 52(41):10749-52. PubMed ID: 24038962
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma.
Ding S; Hackett CL; Liu F; Hackett RG; Bierbach U
ChemMedChem; 2021 Jan; 16(2):412-419. PubMed ID: 32975041
[TBL] [Abstract][Full Text] [Related]
53. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
54. Platinum(II) Metallatriangle: Construction, Coassembly with Polypeptide, and Application in Combined Cancer Photodynamic and Chemotherapy.
Zhang Y; Yan X; Shi L; Cen M; Wang J; Ding Y; Yao Y
Inorg Chem; 2021 Jun; 60(11):7627-7631. PubMed ID: 33974406
[TBL] [Abstract][Full Text] [Related]
55. Polyphosphoester conjugates of dinuclear platinum complex: synthesis and evaluation of cytotoxic and the proapoptotic activity.
Mitova V; Slavcheva S; Shestakova P; Momekova D; Stoyanov N; Momekov G; Troev K; Koseva N
Eur J Med Chem; 2014 Jan; 72():127-36. PubMed ID: 24361525
[TBL] [Abstract][Full Text] [Related]
56. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
[TBL] [Abstract][Full Text] [Related]
57. Bio-fabrication of catalytic platinum nanoparticles and their in vitro efficacy against lungs cancer cells line (A549).
Ullah S; Ahmad A; Wang A; Raza M; Jan AU; Tahir K; Rahman AU; Qipeng Y
J Photochem Photobiol B; 2017 Aug; 173():368-375. PubMed ID: 28646755
[TBL] [Abstract][Full Text] [Related]
58. The comparative study of the DNA binding and biological activities of the quaternized dicnq as a dicationic form and its platinum(II) heteroleptic cationic complex.
Yıldız U; Şengül A; Kandemir I; Cömert F; Akkoç S; Coban B
Bioorg Chem; 2019 Jun; 87():70-77. PubMed ID: 30878811
[TBL] [Abstract][Full Text] [Related]
59. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.
Ma Z; Choudhury JR; Wright MW; Day CS; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2008 Dec; 51(23):7574-80. PubMed ID: 19012390
[TBL] [Abstract][Full Text] [Related]
60. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q
Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
